Andrew Seth Sandler is of Dermata Therapeutics, Inc.. Currently has a direct ownership of 24,184 shares of DRMA, which is worth approximately $32,406. The most recent transaction as insider was on Oct 06, 2022, when has been sold 10,120 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.2K
0% 3M change
0% 12M change
Total Value Held $32,406

Andrew Seth Sandler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 06 2022
BUY
Grant, award, or other acquisition
-
10,120 Added 29.5%
24,184 Common Stock
Jul 07 2022
BUY
Grant, award, or other acquisition
-
8,874 Added 38.69%
14,064 Common Stock, par valu...
Apr 07 2022
BUY
Grant, award, or other acquisition
-
5,190 Added 50.0%
5,190 Common Stock, par valu...

Also insider at

ALPN
ALPINE IMMUNE SCIENCES, INC. Healthcare
ASS

Andrew Seth Sandler

San Diego, CA

Track Institutional and Insider Activities on DRMA

Follow Dermata Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRMA shares.

Notify only if

Insider Trading

Get notified when an Dermata Therapeutics, Inc. insider buys or sells DRMA shares.

Notify only if

News

Receive news related to Dermata Therapeutics, Inc.

Track Activities on DRMA